Xuan Ju
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xuan Ju has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Xiwen Hu
Department of Psychiatry, The Seventh People's Hospital of Hangzhou (Affiliated Mental Health Center, Zhejiang University School of Medicine), Hangzhou, Zhejiang Province, China
2 shared publications Chunyan Zhu
Department of Psychiatry, The Seventh People's Hospital of Hangzhou (Affiliated Mental Health Center, Zhejiang University School of Medicine), Hangzhou, Zhejiang Province, China
1 shared publicationDong-Yu Liu
Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Interdisciplinary Institute of Neuroscience and Technology, Zhejiang University School of Medicine, Hangzhou, 310013, China
1 shared publication- Georg Northoff
Institute of Mental Health Research, University of Ottawa 1 , Ottawa, Canada
1 shared publication - Jiezheng Dong
Department of Psychiatry, The Seventh People's Hospital of Hangzhou (Affiliated Mental Health Center, Zhejiang University School of Medicine), Hangzhou, Zhejiang Province, China
1 shared publication Jin-Fang Han
Affiliated Mental Health Center & Hangzhou Seventh People's Hospital, Interdisciplinary Institute of Neuroscience and Technology, Zhejiang University School of Medicine, Hangzhou, 310013, China
1 shared publication
Latest Publications
- Open Access
- 30 January 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 118, 104854
Establishment and clinical application of a method for converting random quetiapine concentrations to steady-state trough concentrations
- 30 January 2026
- Published by Elsevier in Asian Journal of Psychiatry
- Vol. 118, 104854
Open AccessEstablishment and clinical application of a method for converting random quetiapine concentrations to steady-state trough concentrations
- Open Access
- 6 October 2021
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 32 (10) , 2129-2139
From Molecular to Behavior: Higher Order Occipital Cortex in Major Depressive Disorder
Medial prefrontal cortex (MPFC) and other regions like the occipital cortex (OC) exhibit abnormal neural activity in major depressive disorder (MDD). Their relationship to specific biochemical, psychophysical, and psychopathological changes remains unclear, though. For that purpose, we focus on a particular subregion in OC, namely middle temporal (MT) visual area that is known to mediate the perception of visual motion. Using high-field 7 T magnetic resonance imaging (MRI), including resting state functional MRI and proton magnetic resonance spectroscopy, the amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent signal in MT, MT-seeded functional connectivity (FC), and gamma-aminobutyric acid (GABA) in MT were investigated. Applying the vision motion psychophysical task, the motion suppression index of subjects was also examined. We demonstrate significantly elevated neural variability (as measured by ALFF) in MT together with decreases in both MT GABA and motion suppression in our MDD sample. Unlike in healthy subjects, MT neural variability no longer modulates the relationship of MT GABA and motion suppression in MDD. MT also exhibits reduction in global inter-regional FC to MPFC in MDD. Finally, elevated MT ALFF relates to specifically retardation in behavior as measured by the Hamilton subscore. Together, MT provides a strong candidate for biomarker in MDD.
- 6 October 2021
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 32 (10) , 2129-2139
Open AccessFrom Molecular to Behavior: Higher Order Occipital Cortex in Major Depressive Disorder
Medial prefrontal cortex (MPFC) and other regions like the occipital cortex (OC) exhibit abnormal neural activity in major depressive disorder (MDD). Their relationship to specific biochemical, psychophysical, and psychopathological changes remains unclear, though. For that purpose, we focus on a particular subregion in OC, namely middle temporal (MT) visual area that is known to mediate the perception of visual motion. Using high-field 7 T magnetic resonance imaging (MRI), including resting state functional MRI and proton magnetic resonance spectroscopy, the amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent signal in MT, MT-seeded functional connectivity (FC), and gamma-aminobutyric acid (GABA) in MT were investigated. Applying the vision motion psychophysical task, the motion suppression index of subjects was also examined. We demonstrate significantly elevated neural variability (as measured by ALFF) in MT together with decreases in both MT GABA and motion suppression in our MDD sample. Unlike in healthy subjects, MT neural variability no longer modulates the relationship of MT GABA and motion suppression in MDD. MT also exhibits reduction in global inter-regional FC to MPFC in MDD. Finally, elevated MT ALFF relates to specifically retardation in behavior as measured by the Hamilton subscore. Together, MT provides a strong candidate for biomarker in MDD.